$18.51
-0.08-0.43%
At close: -
$18.51
0.000.00%
After Hours: Dec 24, 1:00 PM EDT
Fulgent Genetics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Fulgent Genetics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-08 | $0.31 | $-0.15 | 306.7 % |
Jun 2024 | 2024-08-02 | $0.15 | $-0.30 | 150.0 % |
Mar 2024 | 2024-05-03 | $-0.01 | $-0.32 | 96.9 % |
Dec 2023 | 2024-02-28 | $0.28 | $-0.29 | 196.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-08 | $71.74M | $71.72M | 0.03 % |
Jun 2024 | 2024-08-02 | $71.03M | $69.07M | 2.83 % |
Mar 2024 | 2024-05-03 | $64.49M | $65.36M | -1.34 % |
Dec 2023 | 2024-02-28 | $70.51M | $66.32M | 6.31 % |
Fulgent Genetics (FLGT) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on November 8, 2024 for Q3.
The Actual EPS was $0.31, which beat the estimate of $-0.15.
The Actual Revenue was $71.7M, which beat the estimate of $71.7M.
Browse earnings estimates, EPS, and revenue on all stocks.